Related references
Note: Only part of the references are listed.Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial
Patricia R. M. Rocco et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Antineoplastic kinase inhibitors: A new class of potent anti-amoebic compounds
Conall Sauvey et al.
PLOS NEGLECTED TROPICAL DISEASES (2021)
Decabromodiphenyl ethane exposure damaged the asymmetric division of mouse oocytes by inhibiting the inactivation of cyclin-dependent kinase 1
Feifei Shi et al.
FASEB JOURNAL (2021)
7,8-Dihydroxyflavone suppresses proliferation and induces apoptosis of human osteosarcoma cells
Jing Zhao et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2021)
Oxidative Stress-Induced Unscheduled CDK1-Cyclin B1 Activity Impairs ER-Mitochondria-Mediated Bioenergetic Metabolism
Jan-Gowth Chang et al.
CELLS (2021)
Analysis of tizoxanide, active metabolite of nitazoxanide, in rat brain tissue and plasma by UHPLC-MS/MS
Sixun Guo et al.
BIOMEDICAL CHROMATOGRAPHY (2020)
Optical density-based image analysis method for the evaluation of hematoxylin and eosin staining precision
Elizabeth Chlipala et al.
JOURNAL OF HISTOTECHNOLOGY (2020)
A network-based analysis of key pharmacological pathways of Andrographis paniculata acting on Alzheimer's disease and experimental validation
Lili Gu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
Quantifying CDK inhibitor selectivity in live cells
Carrow I. Wells et al.
NATURE COMMUNICATIONS (2020)
FTO Demethylates Cyclin D1 mRNA and Controls Cell-Cycle Progression
Mayumi Hirayama et al.
CELL REPORTS (2020)
Cdk1 Controls Global Epigenetic Landscape in Embryonic Stem Cells
Wojciech Michowski et al.
MOLECULAR CELL (2020)
Potential role for nitazoxanide in treating SARS-CoV-2 infection
Paulo Ricardo Martins-Filho et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)
Artificial intelligence, drug repurposing and peer review
Jeremy M. Levin et al.
NATURE BIOTECHNOLOGY (2020)
Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?
Dina B. Mahmoud et al.
JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY (2020)
FragLites-Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation
Daniel J. Wood et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
ROS and Oxidative Stress Are Elevated in Mitosis during Asynchronous Cell Cycle Progression and Are Exacerbated by Mitotic Arrest
Jesse C. Patterson et al.
CELL SYSTEMS (2019)
Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition
Daniel J. Wood et al.
CELL CHEMICAL BIOLOGY (2019)
Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer
Yi Qu et al.
NATURE CHEMICAL BIOLOGY (2018)
N-Acetylcysteine Reduces ROS-Mediated Oxidative DNA Damage and PI3K/Akt Pathway Activation Induced by Helicobacter pylori Infection
Chuan Xie et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma
Xiaoxiong Wang et al.
CELL DEATH & DISEASE (2018)
Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review
Ron Batash et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Temozolomide resistance in glioblastoma multiforme
Sang Y. Lee
GENES & DISEASES (2016)
Nitazoxanide: A first-in-class broad-spectrum antiviral agent
Jean-Francois Rossignol
ANTIVIRAL RESEARCH (2014)
Cyclin B1/Cdk1 Coordinates Mitochondrial Respiration for Cell-Cycle G2/M Progression
Zhaoqing Wang et al.
DEVELOPMENTAL CELL (2014)
A functional perspective of nitazoxanide as a potential anticancer drug
Nicola Di Santo et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2014)
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
Brett E. Johnson et al.
SCIENCE (2014)
Cerium Oxide Nanoparticles Induced Toxicity in Human Lung Cells: Role of ROS Mediated DNA Damage and Apoptosis
Sandeep Mittal et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Development of Highly Potent and Selective Diaminothiazole Inhibitors of Cyclin-Dependent Kinases
Ernst Schonbrunn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells
Hao Liu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Drug Target Identification in Intracellular and Extracellular Protozoan Parasites
Joachim Mueller et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Cdc25 Phosphatases Are Required for Timely Assembly of CDK1-Cyclin B at the G2/M Transition
Oleg Timofeev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
On the transition from the meiotic to mitotic cell cycle during early mouse development
Jacek Z. Kubiak et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2008)
Phosphorylation of the tumor suppressor p33ING1b at Ser-126 influences its protein stability and proliferation of melanoma cells
Marco Garate et al.
FASEB JOURNAL (2007)
Cdk1 is sufficient to drive the mammalian cell cycle
David Santamaria et al.
NATURE (2007)
Nitazoxanide - A review of its use in the treatment of gastrointestinal infections
Vanessa R. Anderson et al.
DRUGS (2007)
Mammalian cyclin-dependent kinases
M Malumbres et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
Nitazoxanide: A new thiazolide antiparasitic agent
LM Fox et al.
CLINICAL INFECTIOUS DISEASES (2005)
From oocyte maturation to the in vitro cell cycle:: the history of discoveries of Maturation-Promoting Factor (MPF) and Cytostatic Factor (CSF)
Y Masui
DIFFERENTIATION (2001)
Share Paper
